Recent Transactions

17-Dec-21
N.A.
United States flag
Target: 

MRO Holdings, Inc. (Panama)

flag not available
Acquiror: 
N.A.

Advised MRO Holdings, a leading airframe maintenance, repair and overhaul (“MRO”) services provider in the Americas, on its term loan financing

29-Sep-21
Pending
$250 million
United States flag
Target: 

Universal Fiber Systems

flag not available
Acquiror: 
N/A

Advised Universal Fiber Systems, a leading supplier of solution-dyed fibers, on its $250mm Unitranche Term Loan financing

09-Sep-21
Pending
$2.1 billion
United Kingdom flag
Target: 

easyJet plc

flag not available
Acquiror: 
N/A

Advising and acting as joint sponsor to UK-based easyJet plc, a leading low-cost European airline carrier, on its £1.2bn fully underwritten rights issue & $400m secured RCF

09-Jun-21
$310 million
Australia flag
Target: 

Australian Unity Funds Management

flag not available
Acquiror: 
N/A

Advised Australian Unity Funds Management on a A$320m equity raising and A$80m cash liquidity offer for Australian Unity Healthcare Property Trust

11-Mar-21
$2.1 billion
Australia flag
Target: 

Education Australia’s 40% Stake in IDP Education

Australia flag
Acquiror: 
Education Australia’s 38 University Shareholders

Advising ASX-listed IDP Education on the restructure of Education Australia’s 40% ownership stake in the business

19-Feb-21
$33 million
U.S.A., U.K. flags
Target: 

Acacia Pharma Group plc

flag not available
Acquiror: 
N/A

Advised Acacia Pharma Group plc, a US headquartered commercial stage biopharmaceutical company incorporated in England and listed in Belgium, on its placing of 10m new ordinary shares at a price of €2.70 per share

01-Feb-21
$292 million
Canada flag
Target: 

Sunwing Airlines and Sunwing Vacations

Canada flag
Acquiror: 
Canada Enterprise Emergency Funding Corp.

Advised Sunwing, a leading Canadian travel company and leisure airline, on its C$375mm financing under the Large Employer Emergency Financing Facility (LEEFF) program administered by the Canada Enterprise Emergency Funding Corp. and overseen by the Government of Canada

01-Oct-20
$2.6 billion
United Kingdom flag
Target: 

Rolls-Royce £2bn Fully Underwritten Rights Issue

flag not available
Acquiror: 
N/A

Advising Rolls-Royce on its Fully Underwritten £2bn Rights Issue, as part of a broader recapitalisation package

01-Oct-20
$1.05 billion
United States flag
Target: 

Akorn, Inc.

flag not available
Acquiror: 
First Lien Term Loan Lenders

Advised Ad Hoc Group of First Lien Term Loan Lenders on Akorn’s in-court recapitalization

29-Sep-20
$200 million
United States flag
Target: 

Travel & Transport

Australia flag
Acquiror: 
Corporate Travel Management

Advising Corporate Travel Management on its acquisition of US-based travel management company Travel & Transport and the associated A$375mm equity raise 

30-Apr-20
$1.9 billion
United States flag
Target: 

American Commercial Lines

flag not available
Acquiror: 
N/A

Advised American Commercial Lines, a leading provider of maritime transportation services, on its pre-packaged in-court recapitalization

03-Feb-20
$650 million
United States flag
Target: 

Clover Wireless

flag not available
Acquiror: 
First Lien Term Loan B Lenders

Advised Ad Hoc Group of First Lien Term Loan B Lenders on the restructuring of 4L Holdings Corporation 

16-Oct-19
$165 million
Germany flag
Target: 

Mann+Hummel

flag not available
Acquiror: 
N/A

Advised Mann+Hummel, a leading global filtration company, on the placement of a green bonded loan

08-May-19
$770 million
United States flag
Target: 

Neovia Logistics

flag not available

Advised Oaktree Capital Management on the comprehensive recapitalization of Neovia

10-Jul-18
$1.1 billion
United Kingdom flag
Target: 

The AA plc

flag not available

Advised the AA plc, the UK’s largest roadside assistance provider, on the refinancing of £825mm of its senior secured facilities

02-May-18
$3.7 billion
Canada flag
Target: 

Concordia International Corp.

flag not available

Advised an Ad Hoc Group of Cross-over Debtholders on Concordia International’s cross-border Canadian restructuring and recapitalization, including a US$586.5mm common equity private placement, the equitization of ~US$1.7bn of unsecured debt and the partial paydown and exchange of ~US$2.2bn of secured debt

28-Mar-18
$NA
United States flag
Target: 

Willbros Group, Inc.

United States flag
Acquiror: 
Primoris Services Corporation

Advised Willbros Group, Inc., a specialty energy infrastructure contractor serving the power and oil & gas industries, on its sale to Primoris Services Corporation

31-Oct-17
$2.0 billion
South Africa, Switzerland flags
Target: 

Hirslanden Private Hospital Group

flag not available

Advised Hirslanden Private Hospital Group, Switzerland's largest private hospital group and a wholly-owned subsidiary of Mediclinic International Plc, on the refinancing of its CHF 2.0 billion senior secured bank debt

06-Oct-17
$18.4 billion
United States flag
Target: 

Caesars Entertainment

flag not available

Advised selected Second Lien Noteholders, including Canyon Capital Advisors, Mason Capital, Paulson & Co. and Soros Fund Management regarding Caesars Entertainment Operating Company’s Chapter 11 proceedings

23-Feb-17
$1.1 billion
United States flag
Target: 

Natural Resource Partners L.P.

flag not available

Advised Natural Resource Partners L.P., a publicly-traded master limited partnership that owns, manages and leases mineral properties in the United States, on a series of recapitalization transactions including the extension of NRP’s near-term debt maturities and the issuance of $250mm of new preferred equity capital to funds managed by Blackstone Tactical Opportunities and from several affiliates of GoldenTree Asset Management L.P.

25-Jan-17
$325 million
United States flag
Target: 

Ad Hoc Group of Senior Secured Noteholders

flag not available

Advised the Ad Hoc Group of Senior Secured Noteholders in connection with the restructuring of Goodman Networks.

04-Oct-16
$223 million
U.S.A., U.K. flags
Target: 

US rights to Toprol-XL (AstraZeneca)

Canada flag
Acquiror: 
Aralez Pharmaceuticals Inc.

Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the US rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.

09-Aug-16
$NA
Australia flag
Target: 

Bionomics Limited

flag not available

Advised ASX-listed Bionomics, a clinical stage biopharmaceutical company focused on the treatment of serious central nervous system disorders and cancer, on a consultation process with shareholders following calls for Board change, leading to the formation of a shareholder working group of leading institutional investors and company-led Board renewal.

08-Jul-16
$555 million
United States flag
Target: 

New Enterprise Stone & Lime Co., Inc.

flag not available

Advised New Enterprise Stone & Lime Co., Inc. on $555 million of secured financings, including a new $450 million senior secured term loan and substantial amendments to its existing $105 million ABL revolver

19-Jan-16
$NA
Brazil flag
Target: 

Recepta Biopharma

Brazil flag
Acquiror: 
Inova Empresa Fundo de Investimento em Participações

Advised Recepta Biopharma on a capital raise

Pages

show all